论文部分内容阅读
本月全球药品研发进展取得成效的药物有41个,较上月大幅减少了1 3个,注册阶段的药品数量大幅减少,其它各研发阶段的药品数量相差不多。进入注册阶段的有17个,比上月大幅减少14个。其中5个为全球首次注册的新活性物质和新制剂,其余12个均
There were 41 drugs that made progress in drug research and development globally this month, a sharp decrease of 13 from the previous month. The number of drugs in the registration phase has dropped sharply while that in other R & D phases has been similar. There were 17 registrations, a sharp decrease of 14 from the previous month. Five of them are the first new active substances and new preparations registered in the world, and the remaining 12 are